Adaptimmune Therapeutics
ADAP
#9327
Rank
$66.39 M
Marketcap
$0.26
Share price
-20.31%
Change (1 day)
-81.02%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Net assets

Net assets on the balance sheet as of December 2024 : $11.84 Million USD

According to Adaptimmune Therapeutics's latest financial reports the company has $11.84 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Adaptimmune Therapeutics - Net assets on balance sheet (from 2014 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$39.51 M-51.74%
2022-12-31$$81.87 M-60.25%
2021-12-31$$0.20 B-39.64%
2020-12-31$$0.34 B175.99%
2019-12-31$$0.12 B-49.92%
2018-12-31$$0.24 B21.63%
2017-12-31$$0.20 B22.18%
2016-12-31$$0.16 B
2015-06-30$$0.25 B10647.07%
2014-06-30$$2.4 M-211.8%
2013-06-30$-$2.16 Million1615.51%
2012-06-30$-$0.13 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-$0.63 Billion-5,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$46.61 M 293.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.76 Million-156.98%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$2.24 B 18,839.99%๐Ÿ‡บ๐Ÿ‡ธ USA